Comments
Loading...
Biofrontera (BFRIW) Forecast
NewsEarningsBiofrontera (BFRIW) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBiofrontera (NASDAQ:BFRIW) Stock Quotes, Forecast and News Summary
Biofrontera Stock (NASDAQ: BFRIW) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biofrontera (BFRIW) stock?
You can purchase shares of Biofrontera (NASDAQ:BFRIW) through any online brokerage.
Who are Biofrontera (BFRIW) competitors?
Other companies in Biofrontera’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).
What is the forecast, or price target, for Biofrontera (BFRIW) stock?
There is no analysis for Biofrontera to provide a consensus price target.
What is the current price for Biofrontera (BFRIW)?
The stock price for Biofrontera (NASDAQ: BFRIW) is $0.0566 last updated February 12, 2025 at 10:28 AM EST.
Does Biofrontera (BFRIW) pay a dividend?
There are no upcoming dividends for Biofrontera.
When is Biofrontera (NASDAQ:BFRIW) reporting earnings?
Biofrontera does not have any upcoming earnings scheduled.
Is Biofrontera (BFRIW) going to split?
There is no upcoming split for Biofrontera.
What sector and industry does Biofrontera (BFRIW) operate in?
Biofrontera is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.